Reimbursed Care Access in Angola

Currently classified as a strictly controlled substance under national and international drug control obligations, with no authorized medical use outside of approved clinical research. #

Currently classified as a strictly controlled substance under national and international drug control obligations, with no authorized medical use outside of approved clinical research. #

Esketamine (the pharmaceutical product marketed as Spravato) does not have any publicly available, country‑level approval or national reimbursement pathway documented for Angola; there is no evidence of a national esketamine (Spravato) rollout or inclusion in an Angolan public formularly as of the date of this report. Internationally, esketamine is a regulated, clinic‑administered medicine with specific REMS/monitoring programs where approved (example: FDA approvals and REMS requirements in the United States) #. Ketamine‑derivative psychiatric uses require formal regulatory approval, defined prescribing/administration controls, and (in most jurisdictions) specific clinic‑level monitoring; no Angolan Ministry of Health approval or national reimbursement documentation was identified in publicly available sources. Note: ketamine (the racemate) is included on the WHO Model List of Essential Medicines as an injectable anesthetic and is commonly used in clinical settings in many low‑ and middle‑income countries, which supports its medical availability for anesthesia in health systems even when specialized psychiatric esketamine programs are not present. #

Ketamine is listed on the World Health Organization Model List of Essential Medicines as an injectable anesthetic and is broadly used in clinical settings for anesthesia and analgesia in low‑ and middle‑income countries, which supports clinical availability in Angolan hospitals and clinics for surgical and emergency indications. #

Medical-context detail (Angola‑relevant practice): national surgical and emergency services in Angola commonly use WHO‑recommended essential anesthetics where available; such use is generally governed by the Angolan Ministry of Health (Ministério da Saúde) medical regulations and by hospital formularies and procurement channels rather than by a specific psychiatric reimbursement pathway. There is no publicly available documentation showing a national reimbursement program for ketamine when used as a psychiatric treatment (for example, for depression) in Angola; any psychiatric use would therefore be off‑label, delivered at provider discretion within private or tertiary care settings and subject to local procurement and funding arrangements. #

Currently classified as a strictly controlled substance under national and international drug control obligations, with no authorized medical use outside of approved clinical research. Plant materials containing DMT (for example, ayahuasca preparations) are typically treated as containing scheduled psychotropic substances under national application of the UN psychotropics convention. # #

Currently classified as a strictly controlled substance under national and international drug control obligations, with no authorized medical use outside of approved clinical research. #

Currently classified as a strictly controlled substance under national and international drug control obligations, with no authorized medical use outside of approved clinical research. (No publicly available Angolan regulatory pathway or reimbursement for ibogaine treatment was identified.) #

Currently classified as a strictly controlled substance under national and international drug control obligations, with no authorized medical use outside of approved clinical research. Because ayahuasca preparations contain DMT, national application of international controls typically results in prohibition except where narrow religious or research exemptions exist; no Angolan religious or research exemptions for ayahuasca were identified in public sources. # #

Currently classified as a strictly controlled substance under national and international drug control obligations, with no authorized medical use outside of approved clinical research. Mescaline and peyote are specifically listed as hallucinogens in many national schedules that implement the UN psychotropics framework. #

Currently classified as a strictly controlled substance under national and international drug control obligations, with no authorized medical use outside of approved clinical research. Many countries place 2C‑family compounds under strict control as psychotropic substances or analogues; no authorised medical or reimbursement pathway exists in Angola. #